The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Screening for lung cancer: 2023 guideline update from the American Cancer Society
Open accessAbstract
Lung cancer is the leading cause of mortality and person‐years of life lost from cancer among US men and women. Early detection has been shown to be associated with reduced lung cancer mortality. Our objective was to update the American Cancer Society (ACS) 2013 lung cancer screening (LCS) guideline for adults at high risk for lung cancer. The guideline is intended to provide guidance for screening to health care providers and their patients who are at high risk for lung cancer due to a history of smoking. The ACS Guideline Development Group (GDG) utilized a systematic review of the LCS literature commissioned for the US Preventive Services Task Force 2021 LCS recommendation update; a second systematic review of lung cancer risk associated with years since quitting smoking (YSQ); literature published since 2021; two Cancer Intervention and Surveillance Modeling Network‐validated lung cancer models to assess the benefits and harms of screening; an epidemiologic and modeling analysis examining the effect of YSQ and aging on lung cancer risk; and an updated analysis of benefit‐to‐radiation‐risk ratios from LCS and follow‐up examinations. The GDG also examined disease burden data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results program. Formulation of recommendations was based on the quality of the evidence and judgment (incorporating values and preferences) about the balance of benefits and harms. The GDG judged that the overall evidence was moderate and sufficient to support a strong recommendation for screening individuals who meet the eligibility criteria. LCS in men and women aged 50–80 years is associated with a reduction in lung cancer deaths across a range of study designs, and inferential evidence supports LCS for men and women older than 80 years who are in good health. The ACS recommends annual LCS with low‐dose computed tomography for asymptomatic individuals aged 50–80 years who currently smoke or formerly smoked and have a ≥20 pack‐year smoking history ( strong recommendation , moderate quality of evidence ). Before the decision is made to initiate LCS, individuals should engage in a shared decision‐making discussion with a qualified health professional. For individuals who formerly smoked, the number of YSQ is not an eligibility criterion to begin or to stop screening. Individuals who currently smoke should receive counseling to quit and be connected to cessation resources. Individuals with comorbid conditions that substantially limit life expectancy should not be screened. These recommendations should be considered by health care providers and adults at high risk for lung cancer in discussions about LCS. If fully implemented, these recommendations have a high likelihood of significantly reducing death and suffering from lung cancer in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,403
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Shared decision making — The pinnacle of patient-centered care
Barry, M. J., & Edgman-Levitan, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1109283 · Cited by 3,433
General, U. S. S. (2014) · PsycEXTRA Dataset · doi:10.1037/e510072014-001 · Cited by 3,324
Clinical Practice Guidelines We Can Trust
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081
The National Comprehensive Cancer Network (NCCN).
Wood, E. H. (2004) · Journal of the Medical Library Association JMLA · Cited by 2,841
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Early Lung Cancer Action Project: overall design and findings from baseline screening
Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J., Altorki, N. K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06093-6 · Cited by 2,508
University of California, San Francisco
(1974) · Medical History · doi:10.1017/s0025727300019682 · Cited by 2,222
Health Risks from Exposure to Low Levels of Ionizing Radiation:: BEIR VII Phase 2
Earth, D. O. (2006) · CERN Document Server (European Organization for Nuclear Research) · Cited by 2,190
American Academy of Family Physicians
(1966) · New England Journal of Medicine · doi:10.1056/nejm196611172752014 · Cited by 1,948
The National Committee for Quality Assurance
Iglehart, J. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609263351322 · Cited by 1,824
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.1117 · Cited by 1,816
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Self-citationIslami, F., Goding Sauer, A., Miller, K. D., Siegel, R. L., Fedewa, S. A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Ma, J., Soerjomataram, I., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21440 · Cited by 1,610
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
GRADE guidelines: 9. Rating up the quality of evidence
Guyatt, G. H., Oxman, A. D., Sultan, S., Glasziou, P., Akl, E. A., Alonso-Coello, P., Atkins, D., Kunz, R., Brozek, J., Montori, V., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.06.004 · Cited by 1,336
Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer
The National Lung Screening Trial Research Team (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209120 · Cited by 1,088
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammemägi, M. C., Chiles, C., Black, W. C., & Aberle, D. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12738 · Cited by 776
Prognostic Indices for Older Adults: A Systematic Review
Yourman, L. C., Lee, S. J., Schonberg, M. A., Widera, E. W., & Smith, A. K. (2012) · JAMA · doi:10.1001/jama.2011.1966 · Cited by 736
American Cancer Society lung cancer screening guidelines
Wender, R., Fontham, E. T. H., Barrera, E., Colditz, G. A., Church, T. R., Ettinger, D. S., Etzioni, R., Flowers, C. R., Scott Gazelle, G., Kelsey, D. K., et al. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21172 · Cited by 723
Self-citationSmith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., & Wender, R. C. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21557 · Cited by 701
Self-citationLehman, C. D., Arao, R. F., Sprague, B. L., Lee, J. M., Buist, D. S. M., Kerlikowske, K., Henderson, L. M., Onega, T., Tosteson, A. N. A., Rauscher, G. H., et al. (2017) · Radiology · doi:10.1148/radiol.2016161174 · Cited by 665
Jonas, D. E., Reuland, D. S., Reddy, S. M., Nagle, M., Clark, S. D., Weber, R. P., Enyioha, C., Malo, T. L., Brenner, A. T., Armstrong, C., et al. (2021) · JAMA · doi:10.1001/jama.2021.0377 · Cited by 633
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21446 · Cited by 571
Self-citationHumphrey, L. L., Deffebach, M., Pappas, M., Baumann, C., Artis, K., Mitchell, J. P., Zakher, B., Fu, R., & Slatore, C. G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00690 · Cited by 534
Performance of Lung-RADS in the National Lung Screening Trial: A Retrospective Assessment
Pinsky, P. F., Gierada, D. S., Black, W., Munden, R., Nath, H., Aberle, D., & Kazerooni, E. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2086 · Cited by 508
United States Life Tables, 2019.
Arias, E., & Xu, J. (2022) · PubMed · Cited by 479
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial
(2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.05.044 · Cited by 464
Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trial
Becker, N., Motsch, E., Trotter, A., Heussel, C. P., Dienemann, H., Schnabel, P. A., Kauczor, H., Maldonado, S. G., Miller, A. B., Kaaks, R., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32486 · Cited by 449
Benefits of Smoking Cessation for Longevity
Taylor, D. H., Hasselblad, V., Henley, S. J., Thun, M. J., & Sloan, F. A. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.6.990 · Cited by 415
Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review
Puliti, D., Duffy, S. W., Miccinesi, G., De Koning, H., Lynge, E., Zappa, M., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012082 · Cited by 407
Infante, M., Cavuto, S., Lutman, F. R., Passera, E., Chiarenza, M., Chiesa, G., Brambilla, G., Angeli, E., Aranzulla, G., Chiti, A., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1475oc · Cited by 365
Tammemägi, M. C., Church, T. R., Hocking, W. G., Silvestri, G. A., Kvale, P. A., Riley, T. L., Commins, J., & Berg, C. D. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001764 · Cited by 358
Self-citationDevelopment and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening
Katki, H. A., Kovalchik, S. A., Berg, C. D., Cheung, L. C., & Chaturvedi, A. K. (2016) · JAMA · doi:10.1001/jama.2016.6255 · Cited by 338
Baseline Characteristics of Participants in the Randomized National Lung Screening Trial
The National Lung Screening Trial Research Team Writing committee:, Aberle, D. R., Adams, A. M., Berg, C. D., Clapp, J. D., Clingan, K. L., Gareen, I. F., Lynch, D. A., Marcus, P. M., & Pinsky, P. F. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq434 · Cited by 322
Informed decision making: What is its role in cancer screening?
Rimer, B. K., Briss, P. A., Zeller, P. K., Chan, E. C. Y., & Woolf, S. H. (2004) · Cancer · doi:10.1002/cncr.20512 · Cited by 320
Meza, R., Jeon, J., Toumazis, I., ten Haaf, K., Cao, P., Bastani, M., Han, S. S., Blom, E. F., Jonas, D. E., Feuer, E. J., et al. (2021) · JAMA · doi:10.1001/jama.2021.1077 · Cited by 320
Patterns of Absolute Risk of Lung Cancer Mortality in Former Smokers
Halpern, M. T., Gillespie, B. W., & Warner, K. E. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.6.457 · Cited by 319
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
Paci, E., Puliti, D., Lopes Pegna, A., Carrozzi, L., Picozzi, G., Falaschi, F., Pistelli, F., Aquilini, F., Ocello, C., Zappa, M., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209825 · Cited by 311
Impact of provider-patient communication on cancer screening adherence: A systematic review
Peterson, E. B., Ostroff, J. S., DuHamel, K. N., D'Agostino, T. A., Hernandez, M., Canzona, M. R., & Bylund, C. L. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.09.034 · Cited by 308
Pinsky, P. F., Church, T. R., Izmirlian, G., & Kramer, B. S. (2013) · Cancer · doi:10.1002/cncr.28326 · Cited by 293
Self-citationLorem, G., Cook, S., Leon, D. A., Emaus, N., & Schirmer, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-61603-0 · Cited by 280
Rampinelli, C., De Marco, P., Origgi, D., Maisonneuve, P., Casiraghi, M., Veronesi, G., Spaggiari, L., & Bellomi, M. (2017) · BMJ · doi:10.1136/bmj.j347 · Cited by 264
Yousaf-Khan, U., van der Aalst, C., de Jong, P. A., Heuvelmans, M., Scholten, E., Lammers, J.-W., van Ooijen, P., Nackaerts, K., Weenink, C., Groen, H., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208655 · Cited by 263
Mazzone, P. J., Silvestri, G. A., Souter, L. H., Caverly, T. J., Kanne, J. P., Katki, H. A., Wiener, R. S., & Detterbeck, F. C. (2021) · Chest · doi:10.1016/j.chest.2021.06.063 · Cited by 254
NELSON lung cancer screening study
Ru Zhao, Y., Xie, X., de Koning, H. J., Mali, W. P., Vliegenthart, R., & Oudkerk, M. (2011) · Cancer Imaging · doi:10.1102/1470-7330.2011.9020 · Cited by 249
Larke, F. J., Kruger, R. L., Cagnon, C. H., Flynn, M. J., McNitt‐Gray, M. F., Wu, X., Judy, P. F., & CODY, D. D. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.11.6533 · Cited by 232
Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers
Aldrich, M. C., Mercaldo, S. F., Sandler, K. L., Blot, W. J., Grogan, E. L., & Blume, J. D. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1402 · Cited by 230
Lung cancer screening as a teachable moment for smoking cessation
Taylor, K. L., Cox, L. S., Zincke, N., Mehta, L., McGuire, C., & Gelmann, E. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.11.015 · Cited by 210
Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study
Tindle, H. A., Stevenson Duncan, M., Greevy, R. A., Vasan, R. S., Kundu, S., Massion, P. P., & Freiberg, M. S. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy041 · Cited by 208
Jeon, J., Holford, T. R., Levy, D. T., Feuer, E. J., Cao, P., Tam, J., Clarke, L., Clarke, J., Kong, C. Y., & Meza, R. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1250 · Cited by 206
ACS report on the cancer-related health checkup.
Eddy, D. M. (1980) · PubMed · Cited by 193
Katki, H. A., Kovalchik, S. A., Petito, L. C., Cheung, L. C., Jacobs, E., Jemal, A., Berg, C. D., & Chaturvedi, A. K. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2701 · Cited by 184
Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum
Hamann, H. A., Ver Hoeve, E. S., Carter-Harris, L., Studts, J. L., & Ostroff, J. S. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.05.014 · Cited by 183
Ashraf, H., Tonnesen, P., Holst Pedersen, J., Dirksen, A., Thorsen, H., & Dossing, M. (2009) · Thorax · doi:10.1136/thx.2008.102475 · Cited by 172
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022
Wood, D. E., Kazerooni, E. A., Aberle, D. R., Berman, A. T., Brown, L. M., Eapen, G. A., Ettinger, D. S., Ferguson, J. S., Hou, L., Kadaria, D., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0036 · Cited by 158
Becker, N., Motsch, E., Gross, M.-L., Eigentopf, A., Heußel, C. P., Dienemann, H., Schnabel, P. A., Eichinger, M., Optazaite, D.-E., Puderbach, M., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000530 · Cited by 146
Lung Cancer Screening, Version 1.2015
Wood, D. E., Kazerooni, E. A., Baum, S. L., Dransfield, M. T., Eapen, G. A., Ettinger, D. S., Hou, L., Jackman, D. M., Klippenstein, D. L., Kumar, R., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0006 · Cited by 139
Sosa, E., D’Souza-Rushton, G. C., Akhtar, A., Sur, M., Love, K., Duffels, J., Raz, D. J., Kim, J. Y., Sun, V. C.-Y., & Erhunmwunsee, L. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21671 · Cited by 137
Morgan, L., Choi, H., Reid, M., Khawaja, A. I., & Mazzone, P. J. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201612-1023oc · Cited by 126
Life-Gained–Based Versus Risk-Based Selection of Smokers for Lung Cancer Screening
Cheung, L. C., Berg, C. D., Castle, P. E., Katki, H. A., & Chaturvedi, A. K. (2019) · Annals of Internal Medicine · doi:10.7326/m19-1263 · Cited by 121
Landy, R., Young, C. D., Skarzynski, M., Cheung, L. C., Berg, C. D., Rivera, M. P., Robbins, H. A., Chaturvedi, A. K., & Katki, H. A. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa211 · Cited by 120
Yip, R., Henschke, C. I., Yankelevitz, D. F., & Smith, J. P. (2014) · Radiology · doi:10.1148/radiol.14132950 · Cited by 114
Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study
Caverly, T. J., Cao, P., Hayward, R. A., & Meza, R. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2561 · Cited by 100
Volk, R. J., Lowenstein, L. M., Leal, V. B., Escoto, K. H., Cantor, S. B., Munden, R. F., Rabius, V. A., Bailey, L. A., Cinciripini, P. M., Lin, H. Y., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20362 · Cited by 97
Early lung cancer action project
Henschke, C. I. (2000) · Cancer · Cited by 96
Ashraf, H., Saghir, Z., Dirksen, A., Pedersen, J. H., Thomsen, L. H., Døssing, M., & Tønnesen, P. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203849 · Cited by 94
A pre-post study testing a lung cancer screening decision aid in primary care
Reuland, D. S., Cubillos, L., Brenner, A. T., Harris, R., Minish, B., & Pignone, M. P. (2018) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-018-0582-1 · Cited by 91
New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines
Brawley, O. W., Byers, T., Chen, A., Pignone, M. P., Ransohoff, D. F., Schenk, M., Smith, R. A., Sox, H. C., Thorson, A. G., & Wender, R. C. (2011) · JAMA · doi:10.1001/jama.2011.1800 · Cited by 90
Self-citationSahar, L., Wills, V. L. D., Liu, K. K., Fedewa, S. A., Rosenthal, L. S., Kazerooni, E. A., Dyer, D. S., & Smith, R. A. (2022) · Cancer · doi:10.1002/cncr.33996 · Cited by 87
Self-citationLung cancer screening: history, current perspectives, and future directions.
Sharma, D., Newman, T., & Aronow, W. S. (2015) · PubMed Central · doi:10.5114/aoms.2015.54859 · Cited by 80
Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients
Zhou, W., Heist, R. S., Liu, G., Park, S., Neuberg, D. S., Asomaning, K., Wain, J. C., Lynch, T. J., & Christiani, D. C. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.05.017 · Cited by 79
Disparities of National Lung Cancer Screening Guidelines in the US Population
Han, S. S., Chow, E. K. H., ten Haaf, K., Toumazis, I., Cao, P., Bastani, M., Tammemägi, M. C., Jeon, J., Feuer, E. J., Meza, R., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa013 · Cited by 73
Risk Model–Based Lung Cancer Screening: A Cost-Effectiveness Analysis
Toumazis, I., Cao, P., de Nijs, K., Bastani, M., Munshi, V. N., Hemmati, M., ten Haaf, K., Jeon, J., Tammemägi, M. C., Gazelle, G. S., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m22-2216 · Cited by 73
Toumazis, I., de Nijs, K., Cao, P., Bastani, M., Munshi, V. N., ten Haaf, K., Jeon, J., Gazelle, G. S., Feuer, E. J., de Koning, H. J., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.4942 · Cited by 70
A Quick Reference Guide for Incidental Findings on Lung Cancer Screening CT Examinations
Dyer, D. S., WHITE, C. S., Thomson, C. C., Gieske, M. R., Kanne, J. P., Chiles, C., Parker, M. S., Menchaca, M., Wu, C. C., & Kazerooni, E. A. (2022) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2022.08.009 · Cited by 68
Tools to Promote Shared Decision-Making in Lung Cancer Screening Using Low-Dose CT Scanning
Fukunaga, M. I., Halligan, K., Kodela, J., Toomey, S., Furtado, V. F., Luckmann, R., Han, P. K. J., Mazor, K. M., & Singh, S. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.05.610 · Cited by 67
Oncology Care Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma
Banerjee, S. C., Haque, N., Schofield, E., Williamson, T. J., Martin, C. M., Bylund, C. L., Shen, M. J., Rigney, M., Hamann, H. A., Parker, P. A., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.11.024 · Cited by 54
Dharod, A., Bellinger, C., Foley, K. L., Case, L. D., & MILLER, D. P. (2019) · Applied Clinical Informatics · doi:10.1055/s-0038-1676807 · Cited by 52
Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening
Kotwal, A., & Schonberg, M. A. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000274 · Cited by 50
Understanding lung cancer screening behaviour using path analysis
Carter‐Harris, L., Slaven, J. E., Monahan, P. O., Draucker, C. B., Vode, E., & Rawl, S. M. (2019) · Journal of Medical Screening · doi:10.1177/0969141319876961 · Cited by 48
Barriers to Lung Cancer Screening With Low-Dose Computed Tomography
Lei, F. (2019) · Oncology nursing forum · doi:10.1188/19.onf.e60-e71 · Cited by 47
Clark, M. A., Gorelick, J. J., Sicks, J. D., Park, E. R., Graham, A. L., Abrams, D. B., & Gareen, I. F. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv037 · Cited by 46
Lung Cancer Mortality in the Lung Screening Study Feasibility Trial
Doroudi, M., Pinsky, P. F., & Marcus, P. M. (2018) · JNCI Cancer Spectrum · doi:10.1093/jncics/pky042 · Cited by 44
Schiffelbein, J. E., Carluzzo, K. L., Hasson, R. M., Alford‐Teaster, J., Imset, I., & Onega, T. (2020) · Journal of Primary Care & Community Health · doi:10.1177/2150132720930544 · Cited by 44
Lung Cancer Stigma Then and Now: Continued Challenges Amid a Landscape of Progress
Hamann, H. A., Williamson, T. J., Studts, J. L., & Ostroff, J. S. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.10.017 · Cited by 39
Landy, R., Cheung, L. C., Young, C. D., Chaturvedi, A. K., & Katki, H. A. (2023) · Cancer · doi:10.1002/cncr.34758 · Cited by 39
Kondo, K. K., Rahman, B., Ayers, C. K., Relevo, R., Griffin, J. C., & Halpern, M. T. (2023) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21808 · Cited by 36
Self-citationJonas, D. E., Reuland, D. S., Reddy, S. M., et al. (2021) · Europe PMC (PubMed Central) · Cited by 32
Meza, R., Cao, P., de Nijs, K., Jeon, J., Smith, R. A., ten Haaf, K., & de Koning, H. J. (2023) · Cancer · doi:10.1002/cncr.34925 · Cited by 30
Self-citationTammemägi, M. C., Darling, G. E., Schmidt, H., Llovet, D., Buchanan, D. N., Leung, Y. W., Miller, B., & Rabeneck, L. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.04.005 · Cited by 29
Pulmonary Nodules, Lung Cancer Screening, and Lung Cancer in the Medicare Population
Pinsky, P. F., Miller, E. A., Faris, N., & Osarogiagbon, R. U. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.12.006 · Cited by 29
Ding, M., Fitzmaurice, G. M., Arvizu, M., Willett, W. C., Manson, J. E., Rexrode, K. M., Hu, F. B., & Chavarro, J. E. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2021-000098 · Cited by 22
Sandler, K. L., Haddad, D. N., Paulson, A. B., Osterman, T. J., Scott, C. C., Poulos, E., & Deppen, S. A. (2021) · Journal of Medical Screening · doi:10.1177/09691413211013058 · Cited by 21
A review of the evidence on the relationship between smoking and lung cancer
Davies, D. F. (1960) · Journal of Chronic Diseases · doi:10.1016/0021-9681(60)90059-x · Cited by 19
Increasing Cancer Screening Rates in Primary Care
Wender, R. C., & Wolf, A. M. D. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.08.001 · Cited by 16
Self-citationSurvival to Age 90 in Men: The Tromsø Study 1974–2018
Brenn, T. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16112028 · Cited by 15
Robbins, H. A., Landy, R., & Ahluwalia, J. S. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2021.7252 · Cited by 8
Time to quit using quit time as a lung cancer screening eligibility criterion
Tammemägi, M. C. (2023) · Cancer · doi:10.1002/cncr.34999 · Cited by 7
Cited by
Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21871 · Cited by 3,060
Self-citationKratzer, T. B., Bandi, P., Freedman, N. D., Smith, R. A., Travis, W. D., Jemal, A., & Siegel, R. L. (2024) · Cancer · doi:10.1002/cncr.35128 · Cited by 512
Self-citation
Metadata
- Authors
- Wolf, A. M. D., Oeffinger, K. C., Shih, T. Y., Walter, L. C., Church, T. R., Fontham, E. T. H., Elkin, E. B., Etzioni, R. D., Guerra, C. E., Perkins, R. B., Kondo, K. K., Kratzer, T. B., Manassaram‐Baptiste, D., Dahut, W. L., & Smith, R. A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2023-11
- Volume
- 74
- Issue
- 1
- Pages
- 50-81
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W4388127863
- Cited by
- 310
- References
- 104
- FWCI
- 49.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.